Early Detection and Diagnosis

You have full text access to this OnlineOpen article

Molecular imaging of mesothelioma by detection of manganese-superoxide dismutase activity using manganese-enhanced magnetic resonance imaging

  1. Sumitaka Hasegawa1,†,*,
  2. Michiko Koshikawa-Yano1,
  3. Shigeyoshi Saito1,2,
  4. Yukie Morokoshi1,
  5. Takako Furukawa1,
  6. Ichio Aoki1,
  7. Tsuneo Saga1

Article first published online: 8 JUL 2010

DOI: 10.1002/ijc.25547

Issue

International Journal of Cancer

International Journal of Cancer

Volume 128, Issue 9, pages 2138–2146, 1 May 2011

Additional Information

How to Cite

Hasegawa, S., Koshikawa-Yano, M., Saito, S., Morokoshi, Y., Furukawa, T., Aoki, I. and Saga, T. (2011), Molecular imaging of mesothelioma by detection of manganese-superoxide dismutase activity using manganese-enhanced magnetic resonance imaging. Int. J. Cancer, 128: 2138–2146. doi: 10.1002/ijc.25547

Author Information

  1. 1

    Molecular Imaging Center, National Institute of Radiological Sciences, Inage-ku, Chiba, Japan

  2. 2

    Graduate School of Medicine, Tohoku University, Aoba-ku, Sendai, Japan

  1. †

    Tel.: +81-43-206-3380, Fax: +81-43-206-0818

*Molecular Imaging Center, National Institute of Radiological Sciences, Anagawa 4-9-1, Inage-ku, Chiba 263-8555, Japan

Publication History

  1. Issue published online: 8 MAR 2011
  2. Article first published online: 8 JUL 2010
  3. Accepted manuscript online: 4 AUG 2010 12:06PM EST
  4. Manuscript Accepted: 29 JUN 2010
  5. Manuscript Received: 26 FEB 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (788K)

References

  • 1
    Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591–603.
  • 2
    Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM Jr, Swanson SJ, Bueno R, Lukanich JM, Baldini EH, Mentzer SJ. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999; 117: 54–63; discussion 63–5.
  • 3
    Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol 2007; 64: 356–66.
  • 4
    Bandoh S, Fujita J, Fukunaga Y, Ohtsuka S, Susaki K, Yang Y, Kobayashi S, Takahara J. Nodular thickening of interlobar fissures: an early manifestation of malignant mesothelioma: a case report. Jpn J Clin Oncol 2001; 31: 82–5.
  • 5
    Yamamoto Y, Kameyama R, Togami T, Kimura N, Ishikawa S, Yamamoto Y, Nishiyama Y. Dual time point FDG PET for evaluation of malignant pleural mesothelioma. Nucl Med Commun 2009; 30: 25–9.
  • 6
    Keele BB Jr, McCord JM, Fridovich I. Superoxide dismutase from Escherichia coli B. A new manganese-containing enzyme. J Biol Chem 1970; 245: 6176–81.
  • 7
    Hasegawa S, Koshikawa M, Takahashi I, Hachiya M, Furukawa T, Akashi M, Yoshida S, Saga T. Alterations in manganese, copper, and zinc contents, and intracellular status of the metal-containing superoxide dismutase in human mesothelioma cells. J Trace Elem Med Biol 2008; 22: 248–55.
  • 8
    Marklund SL, Westman NG, Lundgren E, Roos G. Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res 1982; 42: 1955–61.
  • 9
    Kinnula VL, Pietarinen-Runtti P, Raivio K, Kahlos K, Pelin K, Mattson K, Linnainmaa K. Manganese superoxide dismutase in human pleural mesothelioma cell lines. Free Radic Biol Med 1996; 21: 527–32.
  • 10
    Kahlos K, Anttila S, Asikainen T, Kinnula K, Raivio KO, Mattson K, Linnainmaa K, Kinnula VL. Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma. Am J Respir Cell Mol Biol 1998; 18: 570–80.
  • 11
    Kahlos K, Paakko P, Kurttila E, Soini Y, Kinnula VL. Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma. Br J Cancer 2000; 82: 1022–9.
  • 12
    Kinnula VL, Crapo JD. Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 2004; 36: 718–44.
  • 13
    Mendonca-Dias MH, Gaggelli E, Lauterbur PC. Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Semin Nucl Med 1983; 13: 364–76.
  • 14
    Koretsky AP, Silva AC. Manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed 2004; 17: 527–31.
    Direct Link:
  • 15
    Aoki I, Wu YJ, Silva AC, Lynch RM, Koretsky AP. In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI. Neuroimage 2004; 22: 1046–59.
  • 16
    Culotta VC, Yang M, O'Halloran TV. Activation of superoxide dismutases: putting the metal to the pedal. Biochim Biophys Acta 2006; 1763: 747–58.
  • 17
    Aoki I, Takahashi Y, Chuang KH, Silva AC, Igarashi T, Tanaka C, Childs RW, Koretsky AP. Cell labeling for magnetic resonance imaging with the T1 agent manganese chloride. NMR Biomed 2006; 19: 50–9.
    Direct Link:
  • 18
    Aoki I, Naruse S, Tanaka C. Manganese-enhanced magnetic resonance imaging (MEMRI) of brain activity and applications to early detection of brain ischemia. NMR Biomed 2004; 17: 569–80.
    Direct Link:
  • 19
    Gordon GJ, Jensen RV, Hsiao LL, Gullans SR, Blumenstock JE, Ramaswamy S, Richards WG, Sugarbaker DJ, Bueno R. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 2002; 62: 4963–7.
  • 20
    Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 2005; 7: 109–17.
  • 21
    Genove G, DeMarco U, Xu H, Goins WF, Ahrens ET. A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 2005; 11: 450–4.
  • 22
    Aung W, Hasegawa S, Koshikawa-Yano M, Obata T, Ikehira H, Furukawa T, Aoki I, Saga T. Visualization of in vivo electroporation-mediated transgene expression in experimental tumors by optical and magnetic resonance imaging. Gene Ther 2009; 16: 830–7.
  • 23
    Yang J, Khong PL, Wang Y, Chu AC, Ho SL, Cheung PT, Wu EX. Manganese-enhanced MRI detection of neurodegeneration in neonatal hypoxic-ischemic cerebral injury. Magn Reson Med 2008; 59: 1329–39.
    Direct Link:
  • 24
    Nagamachi Y, Tani M, Shimizu K, Yoshida T, Yokota J. Suicidal gene therapy for pleural metastasis of lung cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene. Cancer Gene Ther 1999; 6: 546–53.
  • 25
    Small WC, DeSimone-Macchi D, Parker JR, Sukerkar A, Hahn PF, Rubin DL, Zelch JV, Kuhlman JE, Outwater EK, Weinreb JC, Brown JJ, de Lange EE, et al. A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis. J Magn Reson Imaging 1999; 10: 15–24.
    Direct Link:
  • 26
    Silva AC, Lee JH, Aoki I, Koretsky AP. Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed 2004; 17: 532–43.
    Direct Link:
  • 27
    Koh DM, Brown G, Meer Z, Norman AR, Husband JE. Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium. AJR Am J Roentgenol 2007; 188: W154–61.
View Full Article (HTML) Get PDF (788K)